Mainstream genetic testing for women with ovarian cancer provides a solid basis for patients to make a well-informed decision about genetic testing

Table 6 Turnaround times for the genetic testing pathways

Days between:	Intervention group n = 133	Control group n = 91	p-value
Diagnosis and pre-test counseling, median (range)	45^a (-29^b – 260)	194^c (6 – 592)	0.000*
- diagnosis and referral	N/A	72^c (-3 – 575)	N/A
- referral and pre-test counseling	N/A	70 (-3 – 240)	N/A
pre-test counseling and communicating test result to patient, median (range)	35^d (11 – 72)	55 (15 – 112)	0.000*
sending letter with test result to patient and additional appointment at genetics department, median (range), n = 21	6 (0 – 58)	N/A	N/A
- normal result, n = 7	20 (6 – 42)
- pathogenic variant or variant of unknown significance, n = 14	5.5 (0^e – 58^f)

N/A Not applicable. All turnaround times are presented in calendar days
^*p ≤ 0.05
^a Based on 121 cases, 12 extreme outliers were excluded
^b One patient was invited for pre-test counseling because a relative of hers had received genetic counseling. Her referral followed after she already had pre-test counseling
^c Based on 78 cases, 13 extreme outliers were excluded
^d Based on 128 cases, 5 extreme outliers were excluded
^e For one patient the number of days between test result and additional appointment was 0 days, because the result was not sent in a letter, but the clinical geneticist visited the patient while she was admitted in the hospital
^f One patient postponed post-test counseling until she had completed her treatment

ISSN: 1897-4287